HillBilll
Wednesday, October 30, 2013
FDA Rescinds Amarin's ANCHOR Study Special Protocol Assessment Agreement
FDA Rescinds Amarin's ANCHOR Study Special Protocol Assessment Agreement
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment